CDK1 and non-small cell lung carcinoma: Here, we demonstrated that CCL21/CCR7 contributed to the time-dependent proliferation of human NSCLC cells by upregulating the expression of cyclin A, cyclin B1, and CDK1 via the ERK pathway.